30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: SpineVision

(2013 sales only)

€10.5MM (~US $14.3MM), +27%

Full-year growth supported by

  • Cash infusion of €7.5MM (~US $10MM), which funded expansion into U.S. market while growing activities in Europe
  • Doubling of U.S. sales following launch of U.L.I.S. (Universal Lumbar Intuitive System) and LUMIS (Lumbar Minimally Invasive System)
  • Expansion of Flex+2 dynamic stabilization platform with prebent rods for hybrid cases